Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Garnet Biotherapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Garnet Biotherapeutics

Garnet Biotherapeutics

Inactive

Garnet BioTherapeutics: A US-based cell therapy firm specializing in dermal regenerative treatments.

HQ
Malvern, AR, US
Founded
2003
Overview
Compare
Fundraising
Employees
Website

Garnet BioTherapeutics is a cell therapy company focused on developing innovative dermal-based regenerative therapies. Their primary areas of application include post-surgical wound repairs, scar revisions, burns, and various dermatological conditions. The company's mission centers on advancing regenerative medicine to improve patient outcomes in dermatology and wound care.

Operating within the United States healthcare industry, Garnet BioTherapeutics aims to leverage cell therapy technologies to address unmet medical needs. Their specialized approach to dermal regeneration positions them as a notable player in the evolving field of regenerative medicine, with potential to significantly impact patient care in their target therapeutic areas.

Garnet Biotherapeutics - Similar Companies

SironRX Therapeutics logo

SironRX Therapeutics

sironrx.com

RegeneRx Biopharmaceuticals logo

RegeneRx Biopharmaceuticals

Endogena Therapeutics logo

Endogena Therapeutics

InGeneron logo

InGeneron

ingeneron.com

Juventas Therapeutics logo

Juventas Therapeutics

juventasinc.com

GentiBio logo

GentiBio

gentibio.com

Spheringenics logo

Spheringenics

Platelet BioGenesis logo

Platelet BioGenesis

CarthroniX logo

CarthroniX

carthronix.com

Celularity logo

Celularity

celularity.com

DermBiont logo

DermBiont

dermbiont.com

BioRegenx logo

BioRegenx

bioregenx.com

AgeX Therapeutics logo

AgeX Therapeutics

HebeCell logo

HebeCell

hebecellcorp.com

Cellebration Life Sciences logo

Cellebration Life Sciences

Garnet Biotherapeutics - Quick Facts

Who are Garnet Biotherapeutics' competitors?

Companies similar to Garnet Biotherapeutics include SironRX Therapeutics, RegeneRx Biopharmaceuticals, Endogena Therapeutics and InGeneron.

When was Garnet Biotherapeutics founded?

Garnet Biotherapeutics was founded in 2003.

Where is Garnet Biotherapeutics' headquarters located?

Garnet Biotherapeutics' headquarters is located in Malvern, AR, US.

When was Garnet Biotherapeutics' last funding round?

Garnet Biotherapeutics' most recent funding round was for $10.4M (USD) in February 2009.

How much has Garnet Biotherapeutics raised to-date?

As of Feb 3, 2009, Garnet Biotherapeutics has raised a total of $10.4M (USD).

Garnet Biotherapeutics - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Main Product
  • Cell Therapy
Tags
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research